Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medina Colic

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Computational and Structural Biotechnology Journal|January 11, 2020
Chemogenetic interactions in human cancer cellsMedina Colic, Traver Hart
Emerging Topics in Life Sciences|December 9, 2021
Common computational tools for analyzing CRISPR screensMedina Colic, Traver Hart
Nucleic Acids Research|November 9, 2022
PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screensLance C Novak, Juihsuan Chou, Medina Colic, et al.
Life Science Alliance|April 14, 2019
A network of human functional gene interactions from knockout fitness screens in cancer cellsEiru Kim, Merve Dede, Walter F Lenoir, et al.
DNA Repair|January 29, 2020
CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactionsDan Su, Xu Feng, Medina Colic, et al.
Genome Biology|June 29, 2022
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactionsEiru Kim, Lance C Novak, Chenchu Lin, et al.
Genome Medicine|August 24, 2019
Identifying chemogenetic interactions from CRISPR screens with drugZMedina Colic, Gang Wang, Michal Zimmermann, et al.
Nature Communications|April 27, 2024
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platformNazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Efficient gene knockout and genetic interactions: the IN4MER CRISPR/Cas12a multiplex knockout platformNazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylaseYohei Yoshihama, Kyle A LaBella, Eiru Kim, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Computational and Structural Biotechnology Journal|January 11, 2020
Chemogenetic interactions in human cancer cellsMedina Colic, Traver Hart
Emerging Topics in Life Sciences|December 9, 2021
Common computational tools for analyzing CRISPR screensMedina Colic, Traver Hart
Nucleic Acids Research|November 9, 2022
PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screensLance C Novak, Juihsuan Chou, Medina Colic, et al.
Life Science Alliance|April 14, 2019
A network of human functional gene interactions from knockout fitness screens in cancer cellsEiru Kim, Merve Dede, Walter F Lenoir, et al.
DNA Repair|January 29, 2020
CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactionsDan Su, Xu Feng, Medina Colic, et al.
Genome Biology|June 29, 2022
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactionsEiru Kim, Lance C Novak, Chenchu Lin, et al.
Genome Medicine|August 24, 2019
Identifying chemogenetic interactions from CRISPR screens with drugZMedina Colic, Gang Wang, Michal Zimmermann, et al.
Nature Communications|April 27, 2024
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platformNazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Efficient gene knockout and genetic interactions: the IN4MER CRISPR/Cas12a multiplex knockout platformNazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylaseYohei Yoshihama, Kyle A LaBella, Eiru Kim, et al.
Pageof 2